TwinKnowledge | $3,700,000 | (Apr 3, 2025)
experial | $2,198,930 | (Apr 3, 2025)
Certified by Founder
Lodge
RheumaGen
start up
United States
- Denver, Colorado
- 10/01/2025
- Series A
- $15,000,000
RheumaGen is a private biotechnology company engineering a new class of therapeutics to cure major autoimmune diseases at their source. RheumaGen focuses on editing the human leukocyte antigen (HLA), or “immune gene,” to develop one-time, curative cell and gene therapies. RheumaGen is headquartered in Aurora, Colorado. For more information, please visit rheumagen.com.
- Industry Biotechnology Research
- Website https://www.rheumagen.com/
- LinkedIn https://www.linkedin.com/company/rheumagen/
Cambrian Network | $5,900,000 | (Apr 3, 2025)
SchoolAI | $25,000,000 | (Apr 3, 2025)
TrialKit | $4,250,000 | (Apr 3, 2025)
Further AI | $5,000,000 | (Apr 3, 2025)
Actively AI | $22,500,000 | (Apr 3, 2025)
Ropes | $3,100,000 | (Apr 3, 2025)